On Friday evening, California State Athletic Commission executive officer George Dodd informed MMAFighting that Rafael “Feijao” Cavalcante (Pictured) is the second former Strikeforce light heavyweight champion to flunk a drug screening in the past six months.
Although Dodd wasn’t able to confirm what substance Feijao tested positive for, he acknowledged the CSAC did issue the Brazilian a letter alerting him of his unfortunate predicament.
It took Feijao all of 33 seconds to dispose of Mike Kyle last month at “Strikeforce: Heavyweight Grand Prix Final” inside HP Pavilion in San Jose.
The 31-year-old now faces a year-long suspension, $2,500 fine and having his victory overturned to a no contest.
Feijao’s longtime manager, Ed Soares, professed they intend on appealing the ban.
“I believe in his innocence, and we’re fighting it,” Soares told MMAFighting. “We stand behind him. There’s a lot of stuff that doesn’t make sense.”
After posting his second consecutive win, Strikeforce CEO Scott Coker stated Feijao likely earned himself a shot at facing fellow former title holder Gegard Mousasi for the vacant 205-pound crown. The breaks are now clearly pumped on that notion.
Muhammed “King Mo” Lawal, the man who defeated Mousasi for the belt only to hand it over to Feijao in his next outing, registered positive for the steroid drostanolone after beating Lorenz Larkin in January. Lawal was subsequently released by the organization and signed by Bellator and TNA Wrestling.
Former Strikeforce featherweight champ Cristiane “Cyborg” Santos was also banned in January for having stanozolol metabolites in her system when she steamrolled Hiroko Yamanaka in December.